Skip to main content
. 2020 May 11;12(5):1206. doi: 10.3390/cancers12051206
Abbreviation Definition
H2AX Phosphorylated histone H2A member X
ABCB1 ATP Binding Cassette Subfamily B Member 1
ALC1 Amplified in liver cancer protein 1
APLF Aprataxin and PNKP like factor
APTX Aprataxin
ATM Ataxia telangiectasia mutated
ATR Ataxia telangiectasia and Rad3 related
BARD1 BRCA associated ring domain 1
BER Base excision repair
BID Twice a day
BRCA1 Breast cancer 1
BRCA2 Breast cancer 2
CHK1 Checkpoint kinase 1
CSCs Cancer stem cells
DDR DNA damage response
DSB double-strand break
DSD Double-strand breaks
FDA Food and Drug Administration
GIS Genomic instability score
HER2 Human epidermal growth factor receptor 2
HGSOC High grade serous ovarian cancer
HR Homologous recombination
LOH Loss of heterozygosity
LST Large-scale State Transitions
MDR1 Multidrug resistance 1
MMR Mismatch repair
MSI Microsatellite instability
NAD Nicotinamide adenine dinucleotide
NER Nucleotide excision repair
NHEJ HR and non-homologous end-joining
NuRD Nucleosome remodeling deacetylase
PARG Poly (ADP) ribose glycohydrolase
PARP Poly (ADP–ribose) polymerase
PARP1 Poly (ADP–ribose) polymerase 1
PARP2 Poly (ADP–ribose) polymerase 2
PARP3 Poly (ADP–ribose) polymerase 3
PARPi Poly (ADP–ribose) polymerase inhibitors
PFS Progression free survival
PNKP Polynucleotide kinase-phosphatase enzyme
RAD51 RAD51 recombinase
RAD51C RAD51 recombinase C
RAD51D RAD51 recombinase D
RCA Replication Comb Assay
SEER Surveillance, Epidemiology, and End Results
SGO Society for Gynecologic Oncology
SigMA signature multivariate analysis
SSB Single-strand breaks
TAI Telomeric Allelic Imbalance
TMB Tumor mutation burden
XRCC1 X-ray repair cross-complementing 1